相似文献
1
A census of human cancer genes.
Nat Rev Cancer. 2004 Mar;4(3):177-83. doi: 10.1038/nrc1299.
2
Distribution of cancer genes in human chromosomes.
Semin Oncol. 2020 Dec;47(6):409-413. doi: 10.1053/j.seminoncol.2020.05.011. Epub 2020 Jun 19.
3
Genome mining for human cancer genes: wherefore art thou?
Trends Mol Med. 2001 May;7(5):187-9. doi: 10.1016/s1471-4914(01)01990-6.
4
[Discovery and clinical application of mutations in the cancer genome].
Nihon Rinsho. 2015 Aug;73(8):1251-5.
5
[Gene polymorphisms].
Bull Cancer. 2010 Nov;97(11):1253-64. doi: 10.1684/bdc.2010.1203.
6
[Towards an inventory of oncogenic mutations in cancer].
Bull Cancer. 2010 Nov;97(11):1223-9. doi: 10.1684/bdc.2010.1200.
7
Oncogenes expand during evolution to withstand somatic amplification.
Ann Oncol. 2018 Nov 1;29(11):2254-2260. doi: 10.1093/annonc/mdy397.
8
Synonymous Somatic Variants in Human Cancer Are Not Infamous: A Plea for Full Disclosure in Databases and Publications.
Hum Mutat. 2017 Apr;38(4):339-342. doi: 10.1002/humu.23163. Epub 2017 Feb 2.
9
MUFFINN: cancer gene discovery via network analysis of somatic mutation data.
Genome Biol. 2016 Jun 23;17(1):129. doi: 10.1186/s13059-016-0989-x.
10
Cancer genome targets: RAF-ing up tumor cells to overcome oncogene addiction.
Expert Rev Anticancer Ther. 2002 Dec;2(6):611-4. doi: 10.1586/14737140.2.6.611.
引用本文的文献
1
Cancer subclone detection based on DNA copy number in single-cell and spatial omic sequencing data.
Nat Methods. 2025 Sep 15. doi: 10.1038/s41592-025-02773-5.
2
Exploring the Therapeutic Potential of Bovine Colostrum for Cancer Therapies.
Int J Mol Sci. 2025 Aug 17;26(16):7936. doi: 10.3390/ijms26167936.
3
Oncodrive3D: fast and accurate detection of structural clusters of somatic mutations under positive selection.
Nucleic Acids Res. 2025 Aug 11;53(15). doi: 10.1093/nar/gkaf776.
4
Targeting Eukaryotic Elongation Factor 1A: How Small-Molecule Inhibitors Suppress Tumor Growth via Diverse Pathways.
Int J Mol Sci. 2025 Jul 29;26(15):7331. doi: 10.3390/ijms26157331.
5
Epigenetics of Endometrial Cancer: The Role of Chromatin Modifications and Medicolegal Implications.
Int J Mol Sci. 2025 Jul 29;26(15):7306. doi: 10.3390/ijms26157306.
6
A core driver gene set identified based on geMER reveals its potential driver mechanism in pan-cancer.
NPJ Precis Oncol. 2025 Aug 9;9(1):278. doi: 10.1038/s41698-025-01060-y.
7
An Insight into Cancer Cells and Disease Progression Through the Lens of Mathematical Modeling.
Curr Issues Mol Biol. 2025 Jun 20;47(7):477. doi: 10.3390/cimb47070477.
8
CaMutQC: An R package for integrative quality control and filtration of cancer somatic mutations.
Comput Struct Biotechnol J. 2025 Jul 16;27:3147-3154. doi: 10.1016/j.csbj.2025.07.011. eCollection 2025.
9
A comprehensive database for identifying and interpreting ctDNA driver genes and variants in cancer.
Sci Data. 2025 Jul 16;12(1):1244. doi: 10.1038/s41597-025-05550-3.
10
Explainable AI Model Reveals Informative Mutational Signatures for Cancer-Type Classification.
Cancers (Basel). 2025 May 22;17(11):1731. doi: 10.3390/cancers17111731.
本文引用的文献
1
Germline p53 mutations in a cohort with childhood sarcoma: sex differences in cancer risk.
Am J Hum Genet. 2003 Apr;72(4):975-83. doi: 10.1086/374567. Epub 2003 Feb 27.
2
PDGFRA activating mutations in gastrointestinal stromal tumors.
Science. 2003 Jan 31;299(5607):708-10. doi: 10.1126/science.1079666. Epub 2003 Jan 9.
3
Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma.
Cancer Cell. 2002 Nov;2(5):367-76. doi: 10.1016/s1535-6108(02)00180-0.
4
The roles of FLT3 in hematopoiesis and leukemia.
Blood. 2002 Sep 1;100(5):1532-42. doi: 10.1182/blood-2002-02-0492.
5
RET/PTC rearrangement in thyroid tumors.
Endocr Pathol. 2002 Spring;13(1):3-16. doi: 10.1385/ep:13:1:03.
6
Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lung.
Cancer Res. 2002 Jul 1;62(13):3659-62.
7
Altered methylation patterns in cancer cell genomes: cause or consequence?
Cancer Cell. 2002 May;1(4):299-305. doi: 10.1016/s1535-6108(02)00061-2.
8
Mutations at coding repeat sequences in mismatch repair-deficient human cancers: toward a new concept of target genes for instability.
Cancer Res. 2002 May 1;62(9):2447-54.
9
Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations.
Nat Genet. 2002 May;31(1):55-9. doi: 10.1038/ng879. Epub 2002 Apr 22.
10
The Pfam protein families database.
Nucleic Acids Res. 2002 Jan 1;30(1):276-80. doi: 10.1093/nar/30.1.276.
Zotero 插件